WFDC2 and ovarian carcinoma: According to the expression of CD147 and HE4 in 96 cases of ovarian cancer, there were 8, 1, 5, and 82 patients in the CD147-/HE4-, D147-/HE4+, CD147+/HE4- and CD147+/HE4+ groups, respectively.